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Abstract
Colorectal cancer (CRC) is ranked third worldwide and seventh in Tanzania. The liver and lungs
are the most commonly involved sites. Disseminated carcinomatosis of the bone marrow
(DCBM) from colorectal carcinoma is rare and typically indicates widespread disease and poor
prognosis. We report a case of a 40-year-old African male, who presented to us with abdominal
distension, weight loss, fever and change in bowel habit over the past month. He underwent
colonoscopy which revealed a necrotic mass in the descending colon. Biopsies were taken, and
histopathology confirmed the presence of poorly differentiated mucin-producing
adenocarcinoma. The patient suffered a colonic perforation after the fifth cycle of
chemotherapy, requiring surgical interventions. Patient's course was complicated by
pancytopenia and bone marrow biopsy revealed infiltration by non-hematopoietic malignant
cells and bone marrow necrosis. Disseminated carcinomatosis of the bone marrow is a rare and
fatal condition; hence high level of clinical suspicion may help in detecting this rare
manifestation of colorectal cancer.
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Colorectal cancer (CRC) is the third frequently diagnosed malignancy and fourth leading cause
of cancer-related death worldwide, accounting for about 1.4 million new cases and 700,000
deaths in 2012. The incidence of CRC in Tanzania is 462/100,000 (3.1%) with a mortality rate of
323/100,000 (2.8%) [1].
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Death in CRC is attributed to the disease recurrence or distant metastases. Distant metastasis
in colorectal cancers occurs in liver and lungs [2]. Peritoneum, adrenal glands, bone, spleen
and brain are less commonly involved sites [3]. Disseminated carcinomatosis of the bone
marrow (DCBM) is a rare condition in which the bone marrow is diffusely invaded with
metastases and frequently associated with disseminated intravascular coagulation (DIC) [4].
Both DCBM and DIC are associated with poor prognoses [5].
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We hereby report a case of patient with colorectal cancer who developed colonic perforation
after his fifth cycle of treatment with folinic acid, 5-fluorouracil and oxaliplatin (FOLFOX-4)
together with bevacizumab (BV) (i.e., FOLOX-4 + BV), and subsequently diagnosed with DCBM
by bone marrow biopsy after persistent pancytopenia.

Case Presentation
A 40-year-old African male presented to our center with the complaint of bloody diarrhea,
accompanied with progressive abdominal distension for one month. The colonoscopy revealed
luminal narrowing of the descending colon with a necrotic mass at the descending colon which
was edematous and bled with minimal contact (Figure 1).

FIGURE 1: Colonoscopy demonstrating luminal narrowing
marked in the descending colon with a necrotic mass which
easily bleeds on contact.

The histopathology revealed poorly differentiated mucin-producing
adenocarcinoma (Figure 2a, 2b, 2c).
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FIGURE 2: (a) H&E – X4 Objective – epithelial tumor cells
floating within lakes of mucin. (b) H&E – X10 Objective –
malignant epithelial cells floating within lakes of mucin. (c)
H&E – X20 Objective – malignant epithelial cells exhibiting high
nuclear to cytoplasmic ration, irregular nuclear contours,
nuclear hyperchromasia and cytoplasmic mucin which in some
cells are seen to indent the nuclei - background mucin is
evident.

Abdominal computed tomography (CT) scan revealed liver metastases with peritoneal
seedlings. The patient was started on palliative chemotherapy FOLFOX-4 + BV and was followed
up on outpatient basis.
However, five days after the fifth cycle of chemotherapy, the patient presented to the
emergency department with severe acute generalized abdominal pain, progressively increasing,
worsened by movement accompanied with abdominal distension and constipation. No nausea,
fever or vomiting was reported. The patient was mildly dehydrated, with the sodium of 150
meq/L, and distended abdomen. The rest of the physical and laboratory examinations were
unremarkable except for white blood cell count of 13.8 x 109. CT examination of the abdomen
was performed, which revealed bowel perforation (Figure 3) and the patient was started on
conservative treatment with the double lumen nasogastric tube (NGT) together to help with
abdominal distension. The patient was also started empirically on antibiotics (cefepime and
metronidazole).
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FIGURE 3: Abdominal CT scan revealing pneumoperitoneum
and intraperitoneal fluid secondary to bowel perforation.

By fifth day of conservative treatment, the patient had developed severe generalized tenderness
and had to undergo exploratory laparotomy, which showed matted bowel, thickened omentum,
turbid fluid with feculent matter in left paracolic area and tumor in the descending colon, stuck
to posterior abdominal wall with a large perforation. Subsequently, the patient underwent loop
ileostomy.
The patient's post-surgical course was complicated by pancytopenia, with white blood cells 0.7
x 109/L; hemoglobin 8 g/dL; and platelets 70 x 10 9/L. Peripheral blood film (PBF) revealed
normocytic, normochromic erythrocytes, leucopenia with no blast cells.
Bone marrow biopsy revealed bone marrow infiltration by non-hematopoietic malignant cells
and bone marrow necrosis, i.e., disseminated carcinomatosis of bone marrow (DCBM) (Figure
4).

2020 Chuwa et al. Cureus 12(4): e7593. DOI 10.7759/cureus.7593

4 of 6

FIGURE 4: H&E – X20 Objective – Hypercellular marrow with
infiltration of clusters of non-haemopoietic cells - some
dispersed within marrow storma.

The patient’s condition got worse, he went into multi-organ system failure, and expired as an
inpatient.

Discussion
This case report represents the first documented case of DCBM of a CRC patient in Tanzania
and the first case in an African race.
DCBM with DIC is an oncological emergency which unfortunately is very difficult to diagnose
when a patient is alive and able to tolerate chemotherapy [6]. Bone marrow metastasis from the
solid tumor is seen in patients with lung, breast and prostate cancer, though is very rare in
patient with colon cancer [7,8]. Micro metastasis of the bone marrow occurs in over one-third of
the patients with stage I-III colon cancer and is associated with poor prognostic factor for
overall survival and disease-free survival [9]. Our patient tolerated five cycles of chemotherapy
(FOLFOX-4 + BV) but died due to complications of bowel perforation.
Although most reported cases of DCBM secondary to CRC are associated with DIC, this case
had no DIC until towards end [4]. In our case, the DCBM impeded the patient’s recovery from
surgery and was diagnosed late due to low suspicious index of DCBM in CRC.

Conclusions
DCBM should be suspected in patients with CRC with abnormal complete blood count (CBC)
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results or DIC. Prompt bone marrow biopsy should be performed to establish a definitive
diagnosis. Early diagnosis of DCBM is important. Clinicians need to watch out for DIC and
counsel the patient and family on the poor prognosis associated with this disease entity.
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